Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas
about
CD74 in Kidney DiseaseHLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.The biological function and significance of CD74 in immune diseases.A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells.
P2860
Q26781254-D579A473-9726-4601-9A12-148510002E77Q38839148-315BF143-75AA-42B0-B562-D4206E1649F4Q38983516-7E2C793A-37BD-460D-ADE2-64C57B18BC1DQ48200903-6D96872C-DEE5-420C-A1FA-35AACF477CE3Q48216696-D95B8307-DB38-47CF-AE23-F1DF5AFB5866Q52715769-24FBE933-9010-4749-BC30-56218FC8A0F1Q55490942-07626A15-4546-435D-9BC6-ED24F248C48B
P2860
Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@ast
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@en
type
label
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@ast
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@en
prefLabel
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@ast
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@en
P2093
P2860
P1433
P1476
Phase I study of the anti-CD74 ...... ously treated B-cell lymphomas
@en
P2093
John P Leonard
June Greenberg
Morton Coleman
Peter Martin
Richard R Furman
Sarah Rutherford
Stanley J Goldsmith
P2860
P304
P356
10.3109/10428194.2015.1028052
P577
2015-03-10T00:00:00Z